Skip to content
Triangle logo TriangleGet started
← Full study record

NCT04985604 · MORE INFO

Limitations, agreements, and source contact

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors · Source last updated 2025-10-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
clinicaltrials@dayonebio.com
organization
Day One Biopharmaceuticals, Inc.
phone
1-650-484-0899
title
Study Director
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
clinicaltrials@dayonebio.com
organization
Day One Biopharmaceuticals, Inc.
phone
1-650-484-0899
title
Study Director

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice